Location
Singapore, Asia
Cheque size
$2M - $20M
Investment Stage
Seed
Series A
Series B
Focus Areas
BioTech
About Investor
Dr. Khoo Shih is the Chief Executive Officer of ClavystBio in Singapore, focusing on BioTech investments. He participates across Seed, Series A, and Series B stages, supporting life sciences innovation. His investment range is between $2M and $20M, with an average check size of around $5M. He focuses on biotechnology companies developing advanced therapeutic and scientific solutions. He works closely with founders on clinical development and commercialization pathways. His leadership role makes him a key decision-maker in biotech investment strategy.
Similar Investors
TN
Tetsu Nakajima
Japan, Asia
$100K - $5M
Pre Seed
,Seed
,BT
Binh Tran
Vietnam, Asia
$500K - $2M
Pre Seed
,Seed
,AC
Alan Chan
Hong Kong, Asia
$100K - $5M
Pre Seed
,Seed
,JF
Jixun Foo
Singapore, Asia
$250K - $25M
Seed
,Series A
,YT
Yinglan Tan
Singapore, Asia
$100K - $5M
Seed
,Series A
,WC
William Chu
Hong Kong, Asia
$1M - $5M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.